Hanall, Yungjin listed in MSCI index

Hanall Pharm and Yungjin Pharm have recently been included in the list of Morgan Stanley Capital International (MSCI) South Korea Index to gauge shares valued $100 million, according to an analyst of Daewoo Securities.

He said that such new listing will give them the potential to attract more foreign investment.

For inclusion in MSCI indices, companies must be above minimum levels in term...